BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19438482)

  • 1. Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
    Pellagatti A; Marafioti T; Paterson JC; Malcovati L; Della Porta MG; Jädersten M; Pushkaran B; George TI; Arber DA; Killick S; Giagounidis A; Hellström-Lindberg E; Cazzola M; Wainscoat JS; Boultwood J
    Br J Haematol; 2009 Jun; 146(1):86-90. PubMed ID: 19438482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
    Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
    Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
    Qian J; Chen Z; Wang W; Cen J; Xue Y
    Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
    Boultwood J; Pellagatti A; Cattan H; Lawrie CH; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Hellström-Lindberg E; Wainscoat JS
    Br J Haematol; 2007 Nov; 139(4):578-89. PubMed ID: 17916100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
    Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
    Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis].
    Qian J; Chen ZX; Wang W; Cen JN; Xue YQ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1260-4. PubMed ID: 15387962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes.
    Schildgen V; Wulfert M; Gattermann N
    Exp Hematol; 2011 Jun; 39(6):666-675.e1. PubMed ID: 21447369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the Doppel protein in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E; Comincini S; Benatti C; Azzalin A; Nano R; Rosti V; Ferretti L; Invernizzi R
    Br J Haematol; 2005 Mar; 128(6):877-84. PubMed ID: 15755294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy.
    Nowak D; Nolte F; Mossner M; Nowak V; Baldus CD; Hopfer O; Noll S; Thiel E; Wagner F; Hofmann WK
    Exp Hematol; 2009 Feb; 37(2):215-224. PubMed ID: 19135900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome.
    Heinrichs S; Berman JN; Ortiz TM; Kornblau SM; Neuberg DS; Estey EH; Look AT
    Br J Haematol; 2005 Jul; 130(1):83-6. PubMed ID: 15982348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
    Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
    Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia.
    Skokowa J; Cario G; Uenalan M; Schambach A; Germeshausen M; Battmer K; Zeidler C; Lehmann U; Eder M; Baum C; Grosschedl R; Stanulla M; Scherr M; Welte K
    Nat Med; 2006 Oct; 12(10):1191-7. PubMed ID: 17063141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for association of lymphoid enhancer-binding factor-1 (LEF1) with the number of functional and inverted teats in pigs.
    Tetzlaff S; Jonas E; Phatsara C; Murani E; Ponsuksili S; Schellander K; Wimmers K
    Cytogenet Genome Res; 2009; 124(2):139-46. PubMed ID: 19420926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
    Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Verma A; Norbury CJ; Hellström-Lindberg E; Wainscoat JS; Boultwood J
    Leukemia; 2010 Apr; 24(4):756-64. PubMed ID: 20220779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
    Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
    Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentially expressed genes in adult familial myelodysplastic syndromes.
    Pradhan A; Mijovic A; Mills K; Cumber P; Westwood N; Mufti GJ; Rassool FV
    Leukemia; 2004 Mar; 18(3):449-59. PubMed ID: 14737073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome.
    Vasikova A; Budinska E; Belickova M; Cermak J; Bruchova H
    Neoplasma; 2009; 56(4):335-42. PubMed ID: 19469654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid enhancer binding factor 1 regulates transcription through gene looping.
    Yun K; So JS; Jash A; Im SH
    J Immunol; 2009 Oct; 183(8):5129-37. PubMed ID: 19783677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.